End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.96 EUR | -2.24% | +19.70% | -66.90% |
05-15 | Acticor: 'new perspectives' in stroke treatment | CF |
05-15 | Acticor Biotech Announces Presentation of the Main Results of the Phase 2/3 Actisave Study in the Treatment of Stroke at ESOC 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-66.90% | 13.71M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- ALACT Stock
- News Acticor Biotech SAS
- Acticor Biotech SAS has completed an IPO in the amount of €15.508613 million.